L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own BMY

Bristol-myers Squibb Co in the Q2 2026 filings. At least 11 of the 91 current managers on file reported a position, worth $5.8bn between them. It is among the largest positions of fewer than a fifth of the current managers on file. The quarter went the other way: 12 managers trimmed or sold out against 3 buying.

Managers holding
11
at least, of 91 current
Combined value
$5.8bn
as reported
Opened
0
new this quarter
Added to
3
already held
Trimmed or sold out
12
4 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
T. Rowe Price Associates Inc
Long-only · $999bn book
$1.8bn0.2%31,707,643+$1.2bn+21,457,405Added
AQR Capital Management LLC
Quantitative · $287bn book
$1.6bn0.5%27,357,486-$221m-2,273,619Trimmed
Acadian Asset Management LLC
Quantitative · $84.2bn book
$668m0.8%11,593,352-$53m-294,316Trimmed
Two Sigma Investments LP
Quantitative · $138bn book
$581m0.4%10,085,383-$119m-1,449,723Trimmed
Arrowstreet Capital LP
Quantitative · $225bn book
$495m0.2%8,585,846-$43m-286,933Trimmed
AllianceBernstein LP
Long-only · $302bn book
$289m0.1%4,757,720+$26m-114,960Trimmed
Man Group PLC
Quantitative · $62.7bn book
$270m0.4%4,682,000-$73m-976,497Trimmed
Woodline Partners LP
Long/short equity · $32.4bn book
$67m0.2%1,167,476-$700k+46,838Added
ExodusPoint Capital Management LP
Multi-strategy · $15.5bn book
$15m0.1%253,748+$7.9m+143,563Added
Brevan Howard Capital Management LP
Macro · $13.5bn book
$9.4m0.1%163,962-$900k-6,549Trimmed
Dodge & Cox
Activist · $191bn book
$2.4m0.0%42,361-$278m-4,580,459Trimmed

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 22 of the 95 managers whose filings are on file listed BMY in Q2 2026, against 21 in Q2 2013. 5 managers fewer than in Q1 2026: 1 started a position; 1 sold out, by its own filing; 5 no longer listed it among the positions read, which can mean a holding below the listed range or a filing not yet made.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
02244Q2 2013: 21Q3 2013: 24Q4 2013: 22Q1 2014: 2514Q2 2014: 24Q3 2014: 24Q4 2014: 20Q1 2015: 2815Q2 2015: 23Q3 2015: 28Q4 2015: 29Q1 2016: 2716Q2 2016: 31Q3 2016: 33Q4 2016: 33Q1 2017: 3617Q2 2017: 36Q3 2017: 34Q4 2017: 35Q1 2018: 3218Q2 2018: 33Q3 2018: 35Q4 2018: 36Q1 2019: 4419Q2 2019: 31Q3 2019: 31Q4 2019: 29Q1 2020: 2920Q2 2020: 35Q3 2020: 31Q4 2020: 28Q1 2021: 3121Q2 2021: 27Q3 2021: 30Q4 2021: 28Q1 2022: 2822Q2 2022: 31Q3 2022: 27Q4 2022: 33Q1 2023: 2923Q2 2023: 29Q3 2023: 32Q4 2023: 30Q1 2024: 2024Q2 2024: 26Q3 2024: 31Q4 2024: 27Q1 2025: 2025Q2 2025: 22Q3 2025: 28Q4 2025: 25Q1 2026: 2726Q2 2026: 22
  • Q2 2013: 21
  • Q3 2013: 24
  • Q4 2013: 22
  • Q1 2014: 25
  • Q2 2014: 24
  • Q3 2014: 24
  • Q4 2014: 20
  • Q1 2015: 28
  • Q2 2015: 23
  • Q3 2015: 28
  • Q4 2015: 29
  • Q1 2016: 27
  • Q2 2016: 31
  • Q3 2016: 33
  • Q4 2016: 33
  • Q1 2017: 36
  • Q2 2017: 36
  • Q3 2017: 34
  • Q4 2017: 35
  • Q1 2018: 32
  • Q2 2018: 33
  • Q3 2018: 35
  • Q4 2018: 36
  • Q1 2019: 44
  • Q2 2019: 31
  • Q3 2019: 31
  • Q4 2019: 29
  • Q1 2020: 29
  • Q2 2020: 35
  • Q3 2020: 31
  • Q4 2020: 28
  • Q1 2021: 31
  • Q2 2021: 27
  • Q3 2021: 30
  • Q4 2021: 28
  • Q1 2022: 28
  • Q2 2022: 31
  • Q3 2022: 27
  • Q4 2022: 33
  • Q1 2023: 29
  • Q2 2023: 29
  • Q3 2023: 32
  • Q4 2023: 30
  • Q1 2024: 20
  • Q2 2024: 26
  • Q3 2024: 31
  • Q4 2024: 27
  • Q1 2025: 20
  • Q2 2025: 22
  • Q3 2025: 28
  • Q4 2025: 25
  • Q1 2026: 27
  • Q2 2026: 22
Their combined reported value
$0$12bn$24bnQ2 2013: $12.2bnQ3 2013: $13.4bnQ4 2013: $14.5bnQ1 2014: $14.8bn14Q2 2014: $14.6bnQ3 2014: $15.8bnQ4 2014: $18.2bnQ1 2015: $20.0bn15Q2 2015: $21.4bnQ3 2015: $19.4bnQ4 2015: $22.5bnQ1 2016: $21.3bn16Q2 2016: $24.0bnQ3 2016: $16.9bnQ4 2016: $20.1bnQ1 2017: $17.9bn17Q2 2017: $17.8bnQ3 2017: $20.2bnQ4 2017: $19.0bnQ1 2018: $19.3bn18Q2 2018: $18.0bnQ3 2018: $19.9bnQ4 2018: $16.6bnQ1 2019: $16.9bn19Q2 2019: $16.8bnQ3 2019: $18.0bnQ4 2019: $24.1bnQ1 2020: $18.9bn20Q2 2020: $18.0bnQ3 2020: $18.8bnQ4 2020: $16.4bnQ1 2021: $15.2bn21Q2 2021: $16.3bnQ3 2021: $14.2bnQ4 2021: $12.9bnQ1 2022: $15.2bn22Q2 2022: $14.8bnQ3 2022: $12.2bnQ4 2022: $10.0bnQ1 2023: $8.4bn23Q2 2023: $7.9bnQ3 2023: $7.5bnQ4 2023: $7.2bnQ1 2024: $6.6bn24Q2 2024: $6.4bnQ3 2024: $7.9bnQ4 2024: $6.6bnQ1 2025: $6.6bn25Q2 2025: $5.6bnQ3 2025: $5.4bnQ4 2025: $7.7bnQ1 2026: $8.3bn26Q2 2026: $8.2bn
  • Q2 2013: $12.2bn
  • Q3 2013: $13.4bn
  • Q4 2013: $14.5bn
  • Q1 2014: $14.8bn
  • Q2 2014: $14.6bn
  • Q3 2014: $15.8bn
  • Q4 2014: $18.2bn
  • Q1 2015: $20.0bn
  • Q2 2015: $21.4bn
  • Q3 2015: $19.4bn
  • Q4 2015: $22.5bn
  • Q1 2016: $21.3bn
  • Q2 2016: $24.0bn
  • Q3 2016: $16.9bn
  • Q4 2016: $20.1bn
  • Q1 2017: $17.9bn
  • Q2 2017: $17.8bn
  • Q3 2017: $20.2bn
  • Q4 2017: $19.0bn
  • Q1 2018: $19.3bn
  • Q2 2018: $18.0bn
  • Q3 2018: $19.9bn
  • Q4 2018: $16.6bn
  • Q1 2019: $16.9bn
  • Q2 2019: $16.8bn
  • Q3 2019: $18.0bn
  • Q4 2019: $24.1bn
  • Q1 2020: $18.9bn
  • Q2 2020: $18.0bn
  • Q3 2020: $18.8bn
  • Q4 2020: $16.4bn
  • Q1 2021: $15.2bn
  • Q2 2021: $16.3bn
  • Q3 2021: $14.2bn
  • Q4 2021: $12.9bn
  • Q1 2022: $15.2bn
  • Q2 2022: $14.8bn
  • Q3 2022: $12.2bn
  • Q4 2022: $10.0bn
  • Q1 2023: $8.4bn
  • Q2 2023: $7.9bn
  • Q3 2023: $7.5bn
  • Q4 2023: $7.2bn
  • Q1 2024: $6.6bn
  • Q2 2024: $6.4bn
  • Q3 2024: $7.9bn
  • Q4 2024: $6.6bn
  • Q1 2025: $6.6bn
  • Q2 2025: $5.6bn
  • Q3 2025: $5.4bn
  • Q4 2025: $7.7bn
  • Q1 2026: $8.3bn
  • Q2 2026: $8.2bn

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Largest increases, by shares

Largest decreases, by shares

ManagerValue over timeFirst listedLargestQ2 2026
T. Rowe Price Associates IncQ2 2013$5.3bn$1.8bn
AQR Capital Management LLCQ2 2013$1.8bn$1.6bn
Fidelity (FMR LLC)Q2 2013$5.5bn$939m
Invesco LtdQ2 2013$1.6bn$924m
Acadian Asset Management LLCQ3 2013$721m$668m
Two Sigma Investments LPQ3 2013$700m$581m
Arrowstreet Capital LPQ2 2017$927m$495m
AllianceBernstein LPQ2 2013$365m$289m
Man Group PLCQ1 2018$449m$270m
Wellington Management Group LLPQ2 2013$9.5bn$226m
Capital World InvestorsQ2 2013$5.8bn$129m
Woodline Partners LPQ4 2019$88m$67m
Neuberger Berman Group LLCQ2 2013$503m$56m
MFS Investment ManagementQ2 2013$873m$55m
Janus Henderson Group LtdQ2 2013$1.4bn$41m
Renaissance Technologies LLCQ2 2013$3.9bnlast listed Q1 2026
Berkshire Hathaway IncQ3 2020$2.1bnlast listed Q4 2021
Viking Global Investors LPQ3 2020$756mlast listed Q4 2021
D. E. Shaw & Co.Q1 2014$734mlast listed Q4 2024
Baupost Group LLCQ1 2019$590mlast listed Q4 2019
Marshall Wace LLPQ1 2014$585mlast listed Q1 2026
Capital Research Global InvestorsQ2 2013$510mlast listed Q1 2025
Harris Associates LPQ2 2013$498mlast listed Q1 2025
Two Sigma Advisers LPQ3 2016$494mlast listed Q4 2025
Millennium Management LLCQ2 2013$480mlast listed Q1 2026

What managers have said about BMY

Arguments made in the managers’ own SEC filings, each checked against the filing and reviewed by a person. A view is as filed on its date, not a current recommendation.

  • Starboard Value LP · Long · 2019-02-28 · 5 reviewed claims

    As part of its case against Bristol-Myers acquiring Celgene, Starboard argues that REVLIMID would represent 63% of Celgene revenue at loss of exclusivity, creating substantial patent-cliff risk.

    The filing on sec.gov
    Not among its listed 13F positions

What BMY is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around BMY →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.